Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$numif Graphic](https://lunarcrush.com/gi/w:26/t:$numif.png) $numif

Cybin's Phase X EMBRACE study receives MHRA approval, with enrollment of XXX participants planned. This development is generating significant engagement and positive sentiment within the community.

### About $numif
A financial and social analysis of the topic $numif.  

### Insights [#](/topic/$numif/insights)
- $numif mentions is at XX which is XXX% higher than it's daily average.
- $numif engagements is at XXX which is XXX% higher than it's daily average.
- $numif creators is at X which is XXX% higher than it's daily average.
- $numif mentions is up XXXXX% from the previous week.
- $numif Creators hit a high of X for the day
- $numif Creators hit an all time of X for the day
- $numif Mentions hit a high of XX for the day
- $numif Mentions hit an all time of XX for the day

### Engagements: XXX [#](/topic/$numif/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$numif/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/$numif/time-series/interactions.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Month**: XXXXX -XX%  
**1-Year High**: XXXXX on 2025-06-10  
**1-Year Low**: X on 2025-05-10  

| Social Network | X   |
| -------------- | -   |
| Engagements    | XXX |
  

  
  
### Mentions: XX [#](/topic/$numif/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$numif/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/$numif/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: X  
**1 Week**: XX +84%  
**1 Month**: XX -XXXX%  
**1-Year High**: XX on 2025-07-12  
**1-Year Low**: X on 2025-05-01  

| Social Network | X  |
| -------------- | -  |
| Mentions       | XX |
  

  
  
### Creators: X [#](/topic/$numif/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$numif/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/$numif/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $numif in the last XX hours which is up XXX% from X in the previous XX hours
**Daily Average**: X  
**1 Week**: X -XX%  
**1 Month**: X -XX%  
**1-Year High**: X on 2025-07-18  
**1-Year Low**: X on 2025-05-01  

The most influential creators that mention $numif in the last XX hours

| Creator                              | Rank | Followers | Posts | Engagements |
| -------                              | ---- | --------- | ----- | ----------- |
| [@psil_ai](/creator/twitter/psil_ai) | X    | XX        | X     | XXX         |

[View More](/list/creators/$numif/100)
  
  
### Sentiment: XXX% [#](/topic/$numif/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$numif/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$numif/time-series/sentiment.tsv)  
**Current Value**: XXX%  
**Daily Average**: XXX%  
**1 Month**: XXX% no change  
**1-Year High**: XXX% on 2025-06-03  
**1-Year Low**: XXX% on 2025-06-03  

**Most Supportive Themes**
- **Cybin's Phase X EMBRACE Study:** (100%) Cybin's Phase X EMBRACE study receives MHRA approval, aiming to enroll XXX participants across multiple sites, indicating progress in developing new treatments for MDD.
  
**Most Critical Themes**
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXX      | XX% | XXX     | XX% | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXX      | XX% | XXX     | XX% | X        | X% |
  


**Top assets mentioned**
In the posts about $numif in the last XX hours

[ATAI Life Sciences (ATAI)](/topic/$atai)
[ATAI Life Sciences (ATAI)](/topic/atai-life)
[Thermo Fisher Scientific Inc. (TMO)](/topic/$tmo)
[Pfizer, Inc. (PFE)](/topic/$pfe)
[Moderna Inc (MRNA)](/topic/$mrna)
[SPDR S&P XXX ETF Trust (SPY)](/topic/$spy)

**Top topics mentioned**
In the posts about $numif in the last XX hours

[$atai](/topic/$atai), [$cmps](/topic/$cmps), [atai life](/topic/atai-life), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [$cybn](/topic/$cybn), [$rvvtf](/topic/$rvvtf), [$mnmd](/topic/$mnmd), [stocks healthcare](/topic/stocks-healthcare), [$psyk](/topic/$psyk), [$seel](/topic/$seel), [signals](/topic/signals), [fisher](/topic/fisher), [$tmo](/topic/$tmo), [pfe](/topic/pfe), [$pfe](/topic/$pfe), [$ghrs](/topic/$ghrs), [$numi](/topic/$numi), [$awknf](/topic/$awknf), [$psil](/topic/$psil), [approved](/topic/approved), [marks](/topic/marks), [australia](/topic/australia), [analog](/topic/analog), [$phrrf](/topic/$phrrf), [$dmttf](/topic/$dmttf), [$envb](/topic/$envb), [acquisition](/topic/acquisition), [$mrna](/topic/$mrna), [$psycf](/topic/$psycf), [$psy](/topic/$psy), [jan](/topic/jan), [tide](/topic/tide), [wct](/topic/wct), [cro](/topic/cro), [iwc](/topic/iwc), [spy](/topic/spy), [$iwc](/topic/$iwc), [$iwm](/topic/$iwm), [$spy](/topic/$spy), [$numiv](/topic/$numiv), [$ttoo](/topic/$ttoo)

### Top Social Posts [#](/topic/$numif/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

""#Cybin's Phase X study EMBRACE to enroll XXX participants at XX sites in US Europe & Australia. Approval from UK MHRA marks progress in developing new treatments for MDD. #innovation" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"  
[@psil_ai](/creator/x/psil_ai) on [X](/post/tweet/1946238828685004993) 2025-07-18 16:01:10 UTC XX followers, XXX engagements


""CYBN receives MHRA approval for Phase X EMBRACE study expected to enroll XXX participants at XX sites. Potential to transform MDD treatment." #innovation #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"  
[@psil_ai](/creator/x/psil_ai) on [X](/post/tweet/1946193556755861773) 2025-07-18 13:01:17 UTC XX followers, XXX engagements


""Cybin's Phase X PARADIGM program progresses with MHRA approval for EMBRACE study aiming to enroll XXX participants and generate critical data for CYB003 in treating MDD. #pharmaceuticals" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"  
[@psil_ai](/creator/x/psil_ai) on [X](/post/tweet/1945876400340103583) 2025-07-17 16:01:01 UTC XX followers, XXX engagements


""Phase X study EMBRACE part of PARADIGM program for CYB003 receives MHRA approval and aims to enroll XXX participants signaling potential for transforming depression treatment. #innovativetherapeutics" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"  
[@psil_ai](/creator/x/psil_ai) on [X](/post/tweet/1945831132840305107) 2025-07-17 13:01:08 UTC XX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$numif Graphic $numif

Cybin's Phase X EMBRACE study receives MHRA approval, with enrollment of XXX participants planned. This development is generating significant engagement and positive sentiment within the community.

About $numif

A financial and social analysis of the topic $numif.

Insights #

  • $numif mentions is at XX which is XXX% higher than it's daily average.
  • $numif engagements is at XXX which is XXX% higher than it's daily average.
  • $numif creators is at X which is XXX% higher than it's daily average.
  • $numif mentions is up XXXXX% from the previous week.
  • $numif Creators hit a high of X for the day
  • $numif Creators hit an all time of X for the day
  • $numif Mentions hit a high of XX for the day
  • $numif Mentions hit an all time of XX for the day

Engagements: XXX #


Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XXX
Daily Average: XXX
1 Month: XXXXX -XX%
1-Year High: XXXXX on 2025-06-10
1-Year Low: X on 2025-05-10

Social Network X
Engagements XXX

Mentions: XX #


Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: X
1 Week: XX +84%
1 Month: XX -XXXX%
1-Year High: XX on 2025-07-12
1-Year Low: X on 2025-05-01

Social Network X
Mentions XX

Creators: X #


Creators Line Chart
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $numif in the last XX hours which is up XXX% from X in the previous XX hours Daily Average: X
1 Week: X -XX%
1 Month: X -XX%
1-Year High: X on 2025-07-18
1-Year Low: X on 2025-05-01

The most influential creators that mention $numif in the last XX hours

Creator Rank Followers Posts Engagements
@psil_ai X XX X XXX

View More

Sentiment: XXX% #


Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XXX%
Daily Average: XXX%
1 Month: XXX% no change
1-Year High: XXX% on 2025-06-03
1-Year Low: XXX% on 2025-06-03

Most Supportive Themes

  • Cybin's Phase X EMBRACE Study: (100%) Cybin's Phase X EMBRACE study receives MHRA approval, aiming to enroll XXX participants across multiple sites, indicating progress in developing new treatments for MDD.

Most Critical Themes

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXX XX% XXX XX% X X%
Total XXX XX% XXX XX% X X%

Top assets mentioned In the posts about $numif in the last XX hours

ATAI Life Sciences (ATAI) ATAI Life Sciences (ATAI) Thermo Fisher Scientific Inc. (TMO) Pfizer, Inc. (PFE) Moderna Inc (MRNA) SPDR S&P XXX ETF Trust (SPY)

Top topics mentioned In the posts about $numif in the last XX hours

$atai, $cmps, atai life, stocks bitcoin treasuries, $cybn, $rvvtf, $mnmd, stocks healthcare, $psyk, $seel, signals, fisher, $tmo, pfe, $pfe, $ghrs, $numi, $awknf, $psil, approved, marks, australia, analog, $phrrf, $dmttf, $envb, acquisition, $mrna, $psycf, $psy, jan, tide, wct, cro, iwc, spy, $iwc, $iwm, $spy, $numiv, $ttoo

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

""#Cybin's Phase X study EMBRACE to enroll XXX participants at XX sites in US Europe & Australia. Approval from UK MHRA marks progress in developing new treatments for MDD. #innovation" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-18 16:01:10 UTC XX followers, XXX engagements

""CYBN receives MHRA approval for Phase X EMBRACE study expected to enroll XXX participants at XX sites. Potential to transform MDD treatment." #innovation #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-18 13:01:17 UTC XX followers, XXX engagements

""Cybin's Phase X PARADIGM program progresses with MHRA approval for EMBRACE study aiming to enroll XXX participants and generate critical data for CYB003 in treating MDD. #pharmaceuticals" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-17 16:01:01 UTC XX followers, XXX engagements

""Phase X study EMBRACE part of PARADIGM program for CYB003 receives MHRA approval and aims to enroll XXX participants signaling potential for transforming depression treatment. #innovativetherapeutics" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-17 13:01:08 UTC XX followers, XXX engagements

$numif
/topic/$numif